Form D · Biotechnology

PIPr Therapeutics, Inc.

Durham, NC · CIK 0001687466

Offering snapshot reported Nov 12, 2025 · SEC filing

Reported sold
$1.5M
Offering amount: $2.5M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 31, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 12, 2025Initial$1,499,995No comparison3SEC filing
Jun 15, 2022Amendment$18,877,921$7,999,999vs Dec 23, 20207SEC filing
Dec 23, 2020Initial$10,877,922No comparison6SEC filing
Mar 4, 2020Initial$1,738,391No comparison4SEC filing
Mar 8, 2019Initial$5,000,000No comparison6SEC filing
Oct 14, 2016Initial$3,000,000No comparison5SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-563664

Source: Form D, filed Nov 12, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Heather Madsen Director, Executive
Bridget Ann Martell Director, Executive
Donnie Mc Grath Director
St. John Donnie Mc Grath Director
Marian Nakada Director
James H. Rosen Director, Executive
Christy Shaffer Director
Moncef Slaoui Director
E. Jonathan Soderstrom Director
Jonathan Soderstrom Director
Clay Thorp Director
Holden Thorp Director
William Wiesler Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
280 S. Mangum St. Suite 350
Durham, NC, 27701